https://www.newsfilecorp.com/release/259998/Phio-Pharmaceuticals-Announces-Agreement-with-U.S.-Manufacturing-Source-for-Drug-Substance
King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical...
phio pharmaceuticalsannouncesagreementmanufacturingsource
https://www.merckmillipore.com/FR/fr/products/biopharmaceutical-manufacturing/drug-substance/HhGb.qB.Y7EAAAFDUAF4saSR,nav
With over 35 years of applications knowledge and support, our products help you address the complex challenges you face in bringing your purified drug to...
drug substancebiopharmaceuticalmanufacturingmerck